Invention Grant
- Patent Title: Pyrimidinone and its derivatives inhibiting factor XIa
-
Application No.: US15644655Application Date: 2017-07-07
-
Publication No.: US10717738B2Publication Date: 2020-07-21
- Inventor: Steve Courtney , Chris Yarnold , Stuart Flanagan , Gareth Brace , John Barker , Osamu Ichihara , Elise Gadouleau , Anthony Richardson , Takashi Kondo , Akira Imagawa , Shingo Nakatani , Ryo Suzuki , Sho Kouyama
- Applicant: ONO PHARMACEUTICAL CO., LTD.
- Applicant Address: JP Osaka
- Assignee: ONO PHARMACEUTICAL CO., LTD.
- Current Assignee: ONO PHARMACEUTICAL CO., LTD.
- Current Assignee Address: JP Osaka
- Agency: Sughrue Mion, PLLC
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@222f9c19 com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@1f07cf6c
- Main IPC: C07D487/04
- IPC: C07D487/04 ; C07D401/14 ; C07D403/14 ; C07D471/04
Abstract:
The present invention provides compounds of the general formula (I), their salts and N-oxides, and solvates and prodrugs thereof (wherein the characters are as defined in the description). The compounds of the general formula (I) are inhibitors of Factor XIa, so that they are useful in the prevention of and/or therapy for thromboembolic diseases.
Public/Granted literature
- US20170305917A1 COMPOUNDS Public/Granted day:2017-10-26
Information query
